Recursion Pharmaceuticals
Vadiraj Kurdekar has extensive experience in the field of computational drug design and medicinal chemistry, currently serving as a Senior Computational Drug Designer at Recursion since December 2024. Prior to this role, Vadiraj held similar positions at Exscientia and Biocon Bristol Myers Squibb Research & Development Center, where responsibilities included advanced computational methodologies in drug discovery. Vadiraj's academic credentials include a Doctor of Philosophy in Medicinal Chemistry from the Birla Institute of Technology and Science, Pilani, earned in 2015, and a Master of Pharmacy in Pharmaceutical Chemistry from the Government College of Pharmacy, Bengaluru. Vadiraj's research experience spans various prestigious institutions, contributing significantly to the fields of computational chemistry and drug development.
This person is not in any teams
This person is not in any offices
Recursion Pharmaceuticals
13 followers
Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease.